United States · Amendment · HAMDT
HAMDT 235 (109th)
An amendment to prohibit use of funds to grant a waiver of a financial conflict of interest requirement under the Federal Food, Drug, and Cosmetic Act for any voting member of an advisory committee or panel of the FDA; or to make a certification under existing law for any such voting member.
Introduced
—
Last action
—
Status
On agreeing to the Hinchey amendment (A012) Agreed to by recorded vote: 218 - 210 (Roll no. 232).
Sponsors
Rep. Hinchey, Maurice D. [D-NY-22]
Subjects
Discovery layer
Source updated
25 February 2022
Records
Official amendment HAMDT 235 (109th) from United States at United States Congress. Status: On agreeing to the Hinchey amendment (A012) Agreed to by recorded vote: 218 - 210 (Roll no. 232)..
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Hinchey, Maurice D. [D-NY-22] · D · Sponsor
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/amendment/109th-congress/hamdt-235
- Open data entity: https://api.congress.gov/v3/amendment/109/hamdt/235
- us · 109-hamdt-235 · source updated 25 February 2022